Researchers at the Terasaki Institute for Biomedical Innovation have developed an innovative delivery system that could ...

Researchers at the Terasaki Institute for Biomedical Innovation have developed an innovative delivery system that could significantly improve the effectiveness of peptide-based cancer vaccines, ...

Adding camrelizumab and rivoceranib to transarterial chemoembolization (TACE) significantly prolonged progression-free ...

Marissa Antonio was just 39 when the 19cm tumour was discovered - and now, Cancer Research UK has revealed liver cancer death ...

FLC is a rare liver cancer with unique genetic traits, often misdiagnosed until advanced. New research and a clinical trial ...

SBRT showed superiority over radiofrequency ablation in local progression-free survival and tumor control in small HCC but ...

January 28, 2025 - Researchers at the Terasaki Institute for Biomedical Innovation have developed an innovative delivery system that ...

New insights into fibrolamellar hepatocellular carcinoma could lead to new drugs and significantly improved health outcomes.

(RTTNews) - Coherus BioSciences, Inc. (CHRS), Wednesday announced final data from its Phase 2 study evaluating casdozokitug in combination with atezolizumab and bevacizumab in patients with ...

The LEAP-015 study is evaluating Merck's Keytruda and Eisai's Lenvima plus chemotherapy in certain types of gastroesophageal ...

For patients with unresectable, nonmetastatic hepatocellular carcinoma, transarterial chemoembolization (TACE) with the ...